Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling and marketing

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Progenity

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AerSale Corp

BriaCell Therapeutics 

Big 5 Sporting Goods

Cassava Sciences Inc

Fintel's list of short squeeze stocks to watch for this week is in. Here are the names that investors should be watching.

Short Squeeze Stocks: PROG, SAVA and 3 Others Experts Think Are Ready to Pop

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:GME) or AMC Entertainment Holdings Inc (NYSE:AMC). A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Cassava Sciences Joins Following Short Report

Alzamend Neuro

Asensus Surgical

Which biotech penny stocks are you watching this month? The post Best Biotech Penny Stocks to Buy in November?

Best Biotech Penny Stocks to Buy in November? 3 to Watch Now

Progenity (PROG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Progenity (PROG) Ahead of Earnings?

SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November 3, 2021. Ms. Howe was also appointed chairperson of the Audit Committee and member of the Nominating and Corporate Governance Committee.

Progenity Announces Appointment of Jill Howe to its Board of Directors

SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on Wednesday, November 10, 2021 after the close of financial markets. Progenity's management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update.

Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update

PROG stock should suffer dilution but its IP strength will lure some in nonetheless. It looks like a biotech to avoid.

Progenity Offers Nothing That Dozens of Other Biotechs Don't

Progenity, Inc. (PROG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Progenity, Inc. (PROG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

WiMi Hologram Cloud

Bit Digital, Inc

Protagonist Therapeutics

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List

Farmmi

Phunware Inc

Why investors are watching these penny stocks right now The post 3 Penny Stocks to Watch That Investors Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks to Watch That Investors Are Buying Right Now

Arbutus Biopharma

Alpine 4 Holdings

Digital Brands Group Inc

Waitr Holdings Inc

Are these penny stocks ready to short squeeze? The post 5 Short Squeeze Penny Stocks To Watch For November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Short Squeeze Penny Stocks To Watch For November 2021

SAN DIEGO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into privately negotiated agreements with certain non-affiliated holders of its existing 7.25% convertible senior notes due 2025 (the "Notes") to exchange an aggregate of $20,175,000 principal amount of Notes for an aggregate of approximately 8,513,850 shares of its common stock, which number of shares of common stock includes shares in respect of the interest make-whole provisions of the indenture under which the Notes were issued. The exchange transactions are expected to close on or about October 26, 2021, subject to customary closing conditions. Progenity will not receive any cash proceeds from the exchange transactions.

Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock

The stock price of Progenity Inc (NASDAQ: PROG) increased by over 30% pre-market today. This is why it happened.

PROG Stock: Why The Price Increased Today

Traders might obsesses over PROG stock's short-squeeze potential, but instead they should consider Progenity's huge addressable market. The post Progenity Stock May Not Be a Great Short-Squeeze Play, But It Has Potential appeared first on InvestorPlace.

Progenity Stock May Not Be a Great Short-Squeeze Play, But It Has Potential

Camber Energy

Northern Dynasty Minerals

Why these penny stocks exploded during today's trading session The post 4 Penny Stocks To Watch That Are Exploding Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks To Watch That Are Exploding Today

Altimeter Growth

Paltalk

Here are five short squeeze stocks many investors are putting on their radar right now as a result of higher short interest and borrow fees. The post Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.

Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop

5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger

Cinedigm

Are these top penny stocks on your watchlist right now? The post Top Penny Stocks to Buy Next Month?

Top Penny Stocks to Buy Next Month? Check These 3 Out For Your List

A massive short squeeze saw the biotech stock rise for the second time this week.

Why Progenity Stock Was Up More Than 24% Friday

Today, investors in Progenity are seeing gains of more than 15% for PROG stock, despite a relative lack of news. Here's what to know.

PROG Stock: 7 Things to Know About Progenity as Shares Soar 15%

Biotricity

Seelos Therapeutics

Why investors are watching these biotech penny stocks right now The post 3 Biotech Penny Stocks to Watch That Are Climbing Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Biotech Penny Stocks to Watch That Are Climbing Right Now

Progenity has a plan in place to save $97 million a year, but how fast can they pull it off, and will it be enough to save PROG stock? The post Progenity Has Seven Quarters Left to Reverse Its Burn Rate appeared first on InvestorPlace.

Progenity Has Seven Quarters Left to Reverse Its Burn Rate

SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohn's & Colitis virtual conference, hosted by the Crohn's & Colitis Foundation, November 18-19, 2021.

Progenity to Participate in Crohn's & Colitis Foundation's Fourth Annual IBD Innovate Conference

Another week is kicking off with five fresh short squeeze stocks that investors should be watching as Shocktober continues. The post Short Squeeze Stocks: PROG, DBGI and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.

News for Progenity Stock (PROG)